This website has been developed to provide information and resources on continuous dopaminergic stimulation with co-careldopa infusion.

Co-careldopa is a combination of levodopa and carbidopa.  Its brand name is Duodopa and it is indicated for use in Advanced Parkinson's Disease where severe motor fluctuations and abnormal voluntary movements (dyskinesia) are present and where other available combinations of Parkinson medicinal products have not given satisfactory results.

If you are a member of the general public, perhaps a patient or carer, please use the menu on the left hand side of the page to access information.

If you are a UK healthcare professional, please click here to register and explore the healthcare professional's site.

If you are already a registered user, please log-on to the healthcare professional site using the HCP Site Login box on the left hand side of the page.

The information provided on Solvay Healthcare Limited’s website is subject to the following Legal and Copyright information.